Literature DB >> 24188068

Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients.

Chengjian Tu1,2, Manoj Jacob Mammen3, Jun Li1,2, Xiaomeng Shen1,2, Xiaosheng Jiang1,2, Qiang Hu4, Jianmin Wang4, Sanjay Sethi3,5, Jun Qu1,2.   

Abstract

Proteomic analysis of bronchoalveolar lavage fluid (BALF) in chronic obstructive pulmonary disease (COPD) patients may provide new biomarkers and deeper understanding of the disease mechanisms but remains challenging. Here we describe an ion-current-based strategy for comparative analysis of BALF proteomes from patients with moderate and stable COPD versus healthy controls. The strategy includes an efficient preparation procedure providing quantitative recovery and a nano-LC/MS analysis with a long, heated column. Under optimized conditions, high efficiency and reproducibility were achieved for each step, enabling a "20-plex" comparison of clinical subjects (n = 10/group). Without depletion/fractionation, a total of 423 unique protein groups were quantified under stringent criteria with at least two quantifiable peptides. Seventy-six proteins were determined as significantly altered in COPD, which represent a diversity of biological processes such as alcohol metabolic process, gluconeogenesis/glycolysis, inflammatory response, proteolysis, and oxidation reduction. Interestingly, altered alcohol metabolism responding to oxidant stress is a novel observation in COPD. The prominently elevated key enzymes involved in alcohol metabolism (e.g., ADH1B, ALDH2, and ALDH3A1) may provide a reasonable explanation for a bewildering observation in COPD patients known for decades: the underestimation of the blood alcohol concentrations through breath tests. These discoveries could provide new insights for identifying novel biomarkers and pathological mediators in clinical studies.

Entities:  

Mesh:

Year:  2013        PMID: 24188068      PMCID: PMC4073647          DOI: 10.1021/pr4007602

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  65 in total

1.  Accurate quantitation of protein expression and site-specific phosphorylation.

Authors:  Y Oda; K Huang; F R Cross; D Cowburn; B T Chait
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Depletion of abundant plasma proteins and limitations of plasma proteomics.

Authors:  Chengjian Tu; Paul A Rudnick; Misti Y Martinez; Kristin L Cheek; Stephen E Stein; Robbert J C Slebos; Daniel C Liebler
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

4.  Human aldehyde dehydrogenase 3A1 inhibits proliferation and promotes survival of human corneal epithelial cells.

Authors:  Aglaia Pappa; Donald Brown; Yiannis Koutalos; James DeGregori; Carl White; Vasilis Vasiliou
Journal:  J Biol Chem       Date:  2005-05-19       Impact factor: 5.157

Review 5.  Chronic obstructive pulmonary disease: the disease and its burden to society.

Authors:  David M G Halpin; Marc Miravitlles
Journal:  Proc Am Thorac Soc       Date:  2006-09

6.  Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage.

Authors:  Aglaia Pappa; Chunhe Chen; Yiannis Koutalos; Alan J Townsend; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2003-05-01       Impact factor: 7.376

7.  Human plasma proteome analysis by multidimensional chromatography prefractionation and linear ion trap mass spectrometry identification.

Authors:  Wen-Hai Jin; Jie Dai; Su-Jun Li; Qi-Chang Xia; Han-Fa Zou; Rong Zeng
Journal:  J Proteome Res       Date:  2005 Mar-Apr       Impact factor: 4.466

8.  Neuron-specific enolase and lung cancer.

Authors:  Demet Karnak; Sumru Beder; Oya Kayacan; Erkan Ibiş; Gül Oflaz
Journal:  Am J Clin Oncol       Date:  2005-12       Impact factor: 2.339

9.  Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin.

Authors:  Chandrassegar Saravanan; Fu-Tong Liu; Ilene K Gipson; Noorjahan Panjwani
Journal:  J Cell Sci       Date:  2009-09-15       Impact factor: 5.285

10.  An ion-current-based, comprehensive and reproducible proteomic strategy for comparative characterization of the cellular responses to novel anti-cancer agents in a prostate cell model.

Authors:  Chengjian Tu; Jun Li; Yahao Bu; David Hangauer; Jun Qu
Journal:  J Proteomics       Date:  2012-09-07       Impact factor: 4.044

View more
  24 in total

1.  Large-Scale, Ion-Current-Based Proteomic Investigation of the Rat Striatal Proteome in a Model of Short- and Long-Term Cocaine Withdrawal.

Authors:  Shichen Shen; Xiaosheng Jiang; Jun Li; Robert M Straubinger; Mauricio Suarez; Chengjian Tu; Xiaotao Duan; Alexis C Thompson; Jun Qu
Journal:  J Proteome Res       Date:  2016-04-11       Impact factor: 4.466

2.  Optimization of Search Engines and Postprocessing Approaches to Maximize Peptide and Protein Identification for High-Resolution Mass Data.

Authors:  Chengjian Tu; Quanhu Sheng; Jun Li; Danjun Ma; Xiaomeng Shen; Xue Wang; Yu Shyr; Zhengping Yi; Jun Qu
Journal:  J Proteome Res       Date:  2015-09-30       Impact factor: 4.466

Review 3.  Quantitative proteomics in cardiovascular research: global and targeted strategies.

Authors:  Xiaomeng Shen; Rebeccah Young; John M Canty; Jun Qu
Journal:  Proteomics Clin Appl       Date:  2014-07-14       Impact factor: 3.494

4.  Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar).

Authors:  Xue Wang; Jin Niu; Jun Li; Xiaomeng Shen; Shichen Shen; Robert M Straubinger; Jun Qu
Journal:  Mol Cell Proteomics       Date:  2018-01-22       Impact factor: 5.911

5.  An IonStar Experimental Strategy for MS1 Ion Current-Based Quantification Using Ultrahigh-Field Orbitrap: Reproducible, In-Depth, and Accurate Protein Measurement in Large Cohorts.

Authors:  Xiaomeng Shen; Shichen Shen; Jun Li; Qiang Hu; Lei Nie; Chengjian Tu; Xue Wang; Benjamin Orsburn; Jianmin Wang; Jun Qu
Journal:  J Proteome Res       Date:  2017-05-25       Impact factor: 4.466

6.  Acrolein inhalation acutely affects the regulation of mitochondrial metabolism in rat lung.

Authors:  C B M Tulen; S J Snow; P A Leermakers; U P Kodavanti; F J van Schooten; A Opperhuizen; A H V Remels
Journal:  Toxicology       Date:  2022-02-10       Impact factor: 4.571

Review 7.  Proteomics: Clinical and research applications in respiratory diseases.

Authors:  Katy C Norman; Bethany B Moore; Kelly B Arnold; David N O'Dwyer
Journal:  Respirology       Date:  2018-08-13       Impact factor: 6.424

8.  New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report.

Authors:  Russell P Bowler; Chris H Wendt; Michael B Fessler; Matthew W Foster; Rachel S Kelly; Jessica Lasky-Su; Angela J Rogers; Kathleen A Stringer; Brent W Winston
Journal:  Ann Am Thorac Soc       Date:  2017-12

9.  Identification of Proteomic Signatures in Chronic Obstructive Pulmonary Disease Emphysematous Phenotype.

Authors:  Shuang Bai; Rui Ye; Cuihong Wang; Pengbo Sun; Di Wang; Yong Yue; Huiying Wang; Si Wu; Miao Yu; Shuhua Xi; Li Zhao
Journal:  Front Mol Biosci       Date:  2021-07-01

10.  Highly multiplexed and reproducible ion-current-based strategy for large-scale quantitative proteomics and the application to protein expression dynamics induced by methylprednisolone in 60 rats.

Authors:  Eslam Nouri-Nigjeh; Siddharth Sukumaran; Chengjian Tu; Jun Li; Xiaomeng Shen; Xiaotao Duan; Debra C DuBois; Richard R Almon; William J Jusko; Jun Qu
Journal:  Anal Chem       Date:  2014-08-06       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.